Join
Live feed
·
INSIDERFilingvia Quantisnow
Abeona Therapeutics Inc. logo

Chief Commercial Officer Vasanthavada Madhav disposed of $1,259 worth of shares (222 units at $5.67), decreasing direct ownership by 0.07% to 303,229 units (SEC Form 4) (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.
ABEO· Abeona Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABEO (Abeona Therapeutics Inc.) and more on Quantisnow.